Exhibit (c)(7)

 

Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover. INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL Project Padlock Kick-Off Materials Goldman Sachs & Co. LLC Strictly Private and Confidential December 2021

Today’s Agenda INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL 8 Process Overview and Timeline 8 Detail on Preparation of Key Process Materials 8 Preliminary Buyer Universe

e summary Process Overview INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL • Optionalitv: Evaluating multiple options concurrently to increase probability of a desirable outcome • Speed: Limit management distraction and gain strategic clarity as soon as possible • Confidentiality: Prevent leaks that could be potentially damaging to share price and commercial efforts • Efficiency: Efficient with management’s time • Reach out to a pre-selected group of potentially interested parties for WholeCo, International Distribution or parts of the Company • Provide limited, prepared private information under NDA before initial indications of value • Solicit initial indications of value for WholeCo as well as International Distribution • Structuring of the final process phase depends on nature and quality of initial indications of value • Preparation phase: -4-5 weeks • Phase 1: -4-6 weeks from initial outreach to indication of value • Phase II: -4-6 weeks is quickest to get to a definitive result, but will depend on Phase I feedback

. Illustrative Timeline INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL December- January February March April -~- Estimated Date _7--+_1_4_!0 1 28 4Q 2021 Earnings ••-— 9 10 11 12 ——- Week Release • • ••••• Feb 24th Preparation Execution Phase II and Final Due Diligence I Preparation Phase I Negotiations (-6 weeks) (-6 weeks) * (4-6 weeks—Who/eGo) * GS I Lincoln I Company to draft • Select group of parties to • Additional management management presentation and enter into NDA and receive access refine detailed financial model management presentation • Access to full legal data and financial model room Prepare clearly broken out detail on International Distribution • Allow for proposals for the • Distribute contract for WholeCo, International review by buyers and their Finalize list of potential partners Distribution only, or other counsel and script I messaging I NDA with segments Management • Negotiate contract during the round to be able to sign with final offer GS I Lincoln to reach out with script to potential buyers (no teaser • Length of round depends required for public company) on proposals received and buyer Indication of Value & Final Offer & • Could be accelerated if Decision Point on Public deemed appropriate to Structure of Phase II Announcement drive value Potential for illustrative timeline to be extended depending on pathway pursued I

• Detailed Workstream Overview INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL Oec 2021 Guiding Principles: s M T w T F s • Capitalize on cuffent market fundamentals 12 ‘D • Solicit interest from buyers that have actively demonstrated knowledge and expertise of the sector and with Covetrus “.-~18 19 • 21 li.l• 24 25 • Clear criteria for process participation (timing, value expectations and diligence approach) 26 .. •••:II 18 • Utilize competitive tension and momentum to accelerate process Jan 2022 ltem(s) Timing s M T w T F s • Prepare outreach script Today Jan 21 1 • • ., • Prepare Financial Model Today—Jan 21 2 8 4 -.,, .... _, • Initiate QoE Today—Jan 21 9 tt ‘II ta t4 15 PIŁ Today—Jan 21 16 .. .. • Zl 22 -...:111-·- • Draft Management Discussion Materials • Prepare Initial Data Room Today—Feb 7 23 25 26 27 28 29 -..!!~...... ., 30 31 • Finalize Buyer Ust Jan 10- Jan 14 • Commence Buyer Outreach with Script and Taking Points Jan 10- Jan 21 Feb 2022 • Negotiate NDAs Jan 10 Jan 21 s M T w T F s 2 3 4 5 • Management Discussions Jan 24- Feb 4 • Distribute Financial Model and Marketing Materials (After NDA Execution) Jan 24- Feb 4 6 7 8 9 10 11 12 Phase I Follow Up Discussion As Needed 13 14 15 16 17 18 19 • Week of Feb 7—Feb 21 Week of Jan 24—• Solicit Initial Indications of Interest Week of Feb 28 20 21 22 23 24 25 26 Week of Feb 28 • Finalize Transaction Perimeter Week of Feb 28 27 28 • Finalize Parties to Move on to Next Round Week of Feb 28 Mar 2022 s M T w T F s • Launch Full Data Room Week of Mar 7 Phase II • Distribute Purchase and Sale Agreements Week of Mar 14 2 3 4 5 Detailed 6 10 12 Week of Mar 7—• Diligence including Management Calls Week of Mar 14 7 8 9 Week of Mar 28 • Share QoE Week of Mar 21 13 14 15 16 17 19 • Solicit Written Indications and Contract Markups with Financing Confirmations Week of Mar 28 20 21 22 23 24 26 Final Negotiations, 27 28 29 30 31 Signing, and • Review Bids, Final Negotiations and Select Final Buyer WeekofApr4 A(;!r 2022 Announcement • Announce and Communicate Transaction Internally, and Externally Week of Apr 11 s M T w T F s Week of Apr 4- 1 2 Week of Apr 11 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Proposed timeline subject to diligence and ability to address diligence questions 17 18 19 20 21 22 23 Potential for longer process should the carve out pathway be pursued 24 25 26 27 28 29 30 ·-·LJ Today D Market Holiday

8 Preparation Phase Work Stream Overview INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL Preparation Phase Work Stream Work Stream Key Action Points Responsibility • Project management • Working group list • Dataroom Project management Management & • Timetable • Organizational GS, Lincoln Organization aspects • Full-potential plan • KPis • Potential upsides CVET, GS, Lincoln, Business Plan I Valuation (including segment Accountants detail) • Management • Positioning • Market analysis I Marketing presentation growth vectors GS, Lincoln, CVET Materials External • Management LRP • Segment level detail (allocations. CVET, GS, Lincoln Financial Model cash flows, etc.) Financial • Historical financials • Segment reporting • Standalone costs Accountants. CVET Reporting • Financial reporting deadlines • Public company costs • Bidder communication • Employee • Press releases GS, Lincoln, CVET, PR Communication guidelines communications Advisor • Leak strategy

8 Preliminary Universe of Potentially Interested INVESTMENT BANKING I DIVISION Parties ‘WLINCOLN INTERNATIO NAL US Focused (Who/eGo only) International Focused (WholeCo I Distribution only) • Large fund to speak for equity • Historical interest in Company • Sector expertise Complementary Fit 1 Technology-focused only. Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL • Working Group List

Working Group List INVESTMENT BANKING I DIVISION Covetrus ‘WLINCOLN INTERNATIO NAL Company/ Address Business Phone Covetrus Tel: 7 Custom House Street Portland, ME 04101 Management Team Ben Wolin Mob: President & Chief Executive Officer Email: Matthew Foulston Mob: Chief Financial Officer Email: Brian McDonald Mob: Vice President, Global Financial Planning & Analysis Email: sl Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Working Group List INVESTMENT BANKING I DIVISION Goldman Sachs ( 1/2) ‘WLINCOLN INTERNATIO NAL Company/Address Business Phone Goldman Sachs Tel: 200 West Street New York, New York 10282 Healthcare Investment Banking Peter van der Goes Tel: Managing Director, Head of Healthcare M&A Mob: Email: Assistant: Michelle Jones-Freeman Tel: Email: Craig Smart Tel: Managing Director Mob: Email: Assistant: Anthony LoBasso Tel: Email: Naomi Leslie Tel: Managing Director Mob: Email: Assistant: Lee Zigner Tel: Email: Philipp Hacker Tel: Vice President Mob: Email: Assistant: Fern Efran Tel: Email: ArialInformation contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Working Group List INVESTMENT BANKING I DIVISION Goldman Sachs (2/2) ‘WLINCOLN INTERNATIO NAL Company/Address Business Phone Goldman Sachs Tel: 200 West Street New York, New York 10282 Healthcare Investment Banking (Cont.) Jeffrey Fedder Tel: Vice President Mob: Email: Assistant: Regina West Tel: Email: Deshawn Lewis Tel: Associate Mob: Email: Assistant: Nicholas Frodella Tel: Email: Rashaad Robinson Tel: Associate Mob: Email: Assistant: Kim Burroughs Tel: Email: Jake Larson Tel: Analyst Mob: Email: Assistant: Kim Burroughs Tel: Email: Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Working Group List INVESTMENT BANKING I DIVISION Lincoln International ‘WLINCOLN INTERNATIO NAL Company/ Address Business Phone Lincoln International LLC Tel: ~ 1 0 North Wacker Drive Chicago, IL 60606 Healthcare Investment Banking Roddy O’Neill Email: Managing Director, Head of Healthcare Mob: Email: Assistant: JaNene Carter Emily Wildes Mob: Managing Director Email: Zhao Hu Mob: Vice President Email: Bryan Samimi Mob: Associate Email: Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Working Group List INVESTMENT BANKING I DIVISION Kirkland & Ellis ‘WLINCOLN INTERNATIO NAL Company/ Address Business Phone Kirkland & Ellis Tel: 601 Lexington Avenue New York, NY 10022 Corporate David Feirstein Tel: Partner Mob: Email: Marshall Shaffer Tel: Partner Email: Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Project Padlock INVESTMENT BANKING I DIVISION Email Distribution List ‘WLINCOLN INTERNATIO NAL Emails Covetrus Goldman Sachs Lincoln International Kirkland & Ellis Information contained herein, marked with [**], has been omitted pursuant to a request for confidential treatment. A complete copy of this document has been supplied to the Securities and Exchange Commission under separate cover.

Disclaimer INVESTMENT BANKING I DIVISION ‘WLINCOLN INTERNATIO NAL These materials have been prepared and are provided by Goldman Sachs on a confidential basis solely for the information and assistance of the Board of Directors (the “Board”) and senior management of Covetrus (the “Company”) in connection with their consideration of the matters referred to herein. These materials and Goldman Sachs’ presentation relating to these materials (the “Confidential Information”) may not be disclosed to any third party or circulated or referred to publicly or used for or relied upon for any other purpose without the prior written consent of Goldman Sachs. The Confidential Information was not prepared with a view to public disclosure or to conform to any disclosure standards under any state, federal or international securities laws or other laws, rules or regulations, and Goldman Sachs does not take any responsibility for the use of the Confidential Information by persons other than those set forth above. Notwithstanding anything in this Confidential Information to the contrary, the Company may disclose to any person the US federal income and state income tax treatment and tax structure of any transaction described herein and all materials of any kind (including tax opinions and other tax analyses) that are provided to the Company relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind. The Confidential Information has been prepared by the Investment Banking Division of Goldman Sachs and is not a product of its research department. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, any other party to any transaction and any of their respective affiliates or any currency or commodity that may be involved in any transaction. Goldman Sachs’ investment banking division maintains regular, ordinary course client service dialogues with clients and potential clients to review events, opportunities, and conditions in particular sectors and industries and, in that connection, Goldman Sachs may make reference to the Company, but Goldman Sachs will not disclose any confidential information received from the Company. The Confidential Information has been prepared based on historical financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources, the management of the Company or other sources (approved for our use by the Company in the case of information from management and non-public information). In preparing the Confidential Information, Goldman Sachs has relied upon and assumed, without assuming any responsibility for independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and Goldman Sachs does not assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance sheet assets and liabilities) of the Company or any other party to any transaction or any of their respective affiliates and has no obligation to evaluate the solvency of the Company or any other party to any transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses contained in the Confidential Information do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold or purchased. Goldman Sachs’ role in any due diligence review is limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the Company. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses, and Goldman Sachs does not assume responsibility if future results are materially different from those forecast. The Confidential Information does not address the underlying business decision of the Company to engage in any transaction, or the relative merits of any transaction or strategic alternative referred to herein as compared to any other transaction or alternative that may be available to the Company. The Confidential Information is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of such Confidential Information and Goldman Sachs assumes no responsibility for updating or revising the Confidential Information based on circumstances, developments or events occurring after such date. The Confidential Information does not constitute any opinion, nor does the Confidential Information constitute a recommendation to the Board, any security holder of the Company or any other person as to how to vote or act with respect to any transaction or any other matter. The Confidential Information, including this disclaimer, is subject to, and governed by, any written agreement between the Company, the Board and/or any committee thereof, on the one hand, and Goldman Sachs, on the other hand. The Confidential Information does not address, nor does Goldman Sachs express any view as to, the potential effects of volatility in the credit, financial and stock markets on the Company, any other party to any transaction or any transaction.